PORTLAND INVESTMENT COUNSEL INC.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1081668 BURLINGTON, A6

Position in REGN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$505,306

+$164,705 QoQ

Shares Held

654

+101.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PORTLAND INVESTMENT COUNSEL INC. holds $5,667,950 across 9 Biotechnology names. REGN ranks #4 (8.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TLX	Telix Pharmaceuticals Ltd	266,200	$2,547,534
2	ONC	BeOne Medicines Ltd.	3,000	$890,910
3	OLMA	Olema Pharmaceuticals, Inc.	50,000	$745,500
4	REGN	Regeneron Pharmaceuticals, Inc. This page	654	$505,306
5	IOVA	Iovance Biotherapeutics, Inc.	130,000	$456,300
6	NUVL	Nuvalent, Inc.	2,000	$204,900
7	ARVN	Arvinas, Inc.	14,000	$148,400
8	RLAY	Relay Therapeutics, Inc.	10,000	$99,500

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$505,306	654	+101.9%	Shares	Sole	2026-05-14
2024-09-30	$340,601	324	0.0%	Shares	Sole	2024-11-14
2024-06-30	$340,533	324	-0.9%	Shares	Sole	2024-08-14
2024-03-31	$314,734	327	0.0%	Shares	Sole	2024-05-15
2023-12-31	$287,200	327	0.0%	Shares	Sole	2024-02-14
2023-09-30	$269,107	327	-0.9%	Shares	Sole	2023-11-13
2023-06-30	$237,118	330	0.0%	Shares	Sole	2023-08-14
2023-03-31	$271,151	330	0.0%	Shares	Sole	2023-05-12
2022-12-31	$238,091	330	0.0%	Shares	Sole	2023-02-14
2022-09-30	$227,327	330	0.0%	Shares	Sole	2022-11-14
2022-03-31	$230,478	330	+0.3%	Shares	Sole	2022-05-13
2021-12-31	$207,770	329	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.